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Abstract 
 
Pharmaceutical residues as micropollutants in water resources is a growing concern. This 
thesis presents a review of the global occurrence of pharmaceutical waste leftover in water 
after treatment in common sewage plants, the potential toxic effects of these chemicals as 
well as the pathways in which they enter and accumulate in the ecosystems. Awareness of 
these pollutants has been increased over the years and steps have been made by the au-
thorities to remove these substances and restore the water quality. However, current tech-
nology and treatment process within existing wastewater treatment plants are insufficient in 
degrading these compounds effectively. Fortunately, several advanced treatment technolo-
gies have been found to effectively treat these pollutants with high removal percentage, such 
as activated carbon, advanced oxidation process using ultraviolet (UV) and/or ozone, bio-
logical treatment using fungi and macrophytes. Each of these technologies follows a differ-
ent process, working mechanism as well as having their advantages and limitations. Overall, 
not any of the discovered technologies are able to totally remove all pharmaceutical residues 
presented in water sources. The best method currently is to combine these technologies 
within a wastewater treatment process in order to maximize all-around removal effectiveness 
and mitigate some of the limitations. Further research and development are still being made 
in this field and better treatment techniques will hopefully be discovered in the near future.   
Keywords pharmaceuticals, wastewater, micropollutants, ozone, acti-
vated carbon, ultraviolet, biological treatment 
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1 Introduction 
The consumption and manufacturing process of pharmaceutical products (e.g. medi-
cines, personal care products) is prevalent in today’s society. While bringing many ben-
efits, these products leave a trace after usage. After consumption, drugs are ingested 
and undergo metabolic reactions. However, a considerable fraction of the original prod-
ucts remain unchanged and leave the living organisms (humans & animals) along with 
an amount of their metabolites via excretion and enter the sewage. Chemicals discharge 
from pharmaceutical manufacturing, hospital services, animal husbandry and agricultural 
activities also find its way into the sewage system (aus der Beek et al., 2016). These 
factors result in the presence of pharmaceutical traces in the raw influent of the WWTPs. 
Small doses of these chemical continue to remain in the effluent after the treatment pro-
cess and are discharged into the environment (Kolpin et al., 2002).  
Over the last years, the occurrence of pharmaceuticals in water bodies has attracted 
more attention from environmental administrative authorities as potential dangerous pol-
lutants to the environment as well as to the living entities (Kümmerer, 2009). They are 
found to be present in all type of water bodies: surface water, ground water, tap/drinking 
water, sewage, wastewater treatment plants (WWTPs) influent/effluent, animal manure 
and agricultural soil with low concentration (ng/L to μg/L range). These substances are 
usually water soluble, biologically active compounds but not biodegrade easily (Jiang et 
al., 2013). They can remain in water bodies and accumulate until reaching a critical dose 
which can pose a harmful effect towards the ecosystem and human health (Sirés and 
Brillas, 2012). With population continues to age and living quality raising every year, 
pharmaceutical consumption and discharge quantity might be set to increase in future 
years. 
Typical types of pharmaceutical pollutants found in the sewage and water environment 
are (according to Verlicchi et al., 2012): 
 Analgesics/anti-inflammatories: painkillers and drugs that reduce inflammation. 
 Antibiotics: antimicrobial medicine applied in the treatment of bacterial infections. 
 Antidiabetic: drugs used in diabetes treatment.  
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 Antifungal:  medication used to treat and prevent mycoses (fungal infections) 
 Anti-hypertensives: drugs prescribed for curing hypertension (high blood pres-
sure) and their complications.  
 Beta-blockers: pharmaceuticals used to treat abnormal heart rhythms, hyperten-
sion, heart attacks and their complications.   
 Diuretics: drugs that promote diuresis i.e. increased production of urine and ex-
cretion of water from bodies.  
 Lipid regulators: cholesterol-reducing drugs used in treatment of high fat (lipids) 
levels in the blood.  
 Psychiatric drugs: medications for mental illnesses.  
 Receptor antagonists: drugs that dampen or completely block the neurotransmit-
ter-mediated response to another chemical substance. 
 Synthetic Hormones/Estrogens: artificial female human hormones used in treat-
ment of menopausal symptoms. 
 Antiseptic: chemicals applied to living skin tissue to destroy bacteria to treat and 
prevent infection. 
 Contrast agent (or contrast medium): compounds used in improving the contrast 
of structures or fluids in medical imaging. 
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2 Pharmaceutical residues in water  
2.1 Occurrence 
The presence of pharmaceutical residues has been shown to be global (aus der Beek et 
al., 2016). Figure 1 shows that every single continent on the planet has records on de-
tection of pharmaceuticals in the aquatic system. Within Europe and North America, 
painkillers, cardiovascular drugs, and antibiotics are the most popular form of pharma-
ceutical residues. The heavy occurrence is obviously apparent in developed countries  
since it is a known fact that the application of pharmaceuticals in medical treatment, 
agriculture, research is copious in nowadays modern era. However, developing regions 
of the world such as Africa and South America also find their water contaminated with 
these chemicals. Carbamazepine, sulfamethoxazole, ibuprofen, trimethoprim, and para-
cetamol are presented most abundantly in Africa, while very high concentrations of syn-
thetic hormones such as estrone, estradiol, and ethinylestradiol were commonly found 
in South America. Asian water especially has very high concentration of antibiotics 
(ciprofloxacin, erythromycin, norfloxacin, and ofloxacin) which can be attributed to the 
heavy consumption and production of these drugs. While limited severe cases of adverse 
effect have been reported, the Earth’s water source should be kept clean and free of 
unwanted leftovers for our present and future generations. 
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Figure 1. Occurrence of pharmaceuticals in surface water, ground water and drinking 
water in the world (Weber, 2013) 
Table 1 depicts the most common chemicals detected in aquatic systems and their rec-
orded concentrations from all over the globe. They are medicines that are used today to 
treat and prevent diseases in humans and animals. Globally, the most popular pharma-
ceuticals pollutants are painkillers (Naproxen, Aspirin, Diclofenac, Paracetamol) with de-
tected frequency of 31 % of all total records with median concentration of 230 ng/L. Sec-
ond most important pharmaceutical group is antibiotics group (Sulfamethoxazole, Ciprof-
loxacin, Trimethoprim, Ofloxacin, Norfloxacin) with a 21 % detection frequency and a 
8128 ng/L median concentration (Hughes et al., 2013). As can be seen in Table 1, the 
concentration of each individual residue is very low, with the two highest being the Anti-
biotics Ciprofloxacin (18.99 µg/L) and Norfloxacin (3.457 µg/L); the rest of them are in 
the range of 0.003 to less than 1 µg/L. Maximum concentrations are recorded from dif-
ferent locations globally, with each one of those pharmaceuticals being popular in usage 
within a particular region. Despite the fact that the concentrations are low, it should be 
noted that these chemicals should not have been released into the water at the first 
place. 
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Table 1. Common pharmaceutical pollutants in water bodies, their average and maxi-
mum global concentration (aus der Beek et al., 2016) 
Type of phar-
maceutical 
Compound 
name 
Compound 
structure 
Average con-
centration 
(µg/L) 
Maximum con-
centration 
(µg/L) 
Analge-
sics/anti-in-
flammatories 
Acetylsalicylic 
acid (aspirin)    
0.922 20.96 
Paracetamol 
 
0.161 230.0 
Ibuprofen 
 
0.108 303.0 
Naproxen 
 
0.050 32.0 
Diclofenac 
 
0.032 18.74 
Antibiotics Ciprofloxacin 
 
18.99 6500.0 
Norfloxacin  
 
3.457 520.0 
Ofloxacin 
 
0.278 17.7 
Sulfamethoxa-
zole  
0.095 29.0 
Trimethoprim 
 
0.037 13.6 
Anti-epileptics
  
Carbamaze-
pine  
0.187 8.05 
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Type of phar-
maceutical 
Compound 
name 
Compound 
structure 
Average con-
centration 
(µg/L) 
Maximum con-
centration 
(µg/L) 
Synthetic Es-
trogens 
Ethinylestra-
diol   
0.043 5.9 
Estrone 
 
0.016 5.0 
Estriol  
 
0.009 0.48 
Estradiol 
 
0.003 0.012 
 
2.2 Pathways 
Pharmaceutical residues can enter the environment through multiple complex routes. 
Figure 2 presents some of the most common exposure pathways of pharmaceutical 
products from manufacturing source to wastewater then into living bodies. 
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Figure 2. Exposure pathways of pharmaceutical products 
Pharmaceuticals can enter the wastewater as early as during the production process. It 
had been found that effluent from pharmaceutical production site contains a large 
amount of chemicals which arises from the manufacturing process (Larsson et al., 2007). 
After the production phase, pharmaceutical products are delivered to pharmacies, health 
facilities then to the consumers. Most of the pharmaceuticals are consumed by hospitals, 
healthcare facilities, private consumers and agriculture (with farming, animal husbandry 
being the most notable) to treat and prevent diseases. When consumed by humans or 
animals, pharmaceutical products are metabolized to a range of degrees. Their dis-
charged metabolites and parent (original) compounds can be found in urine or feces 
which go to the sewage system. After that, the biological, chemical and physical pro-
cesses within WWTPs and the receiving water bodies can further alter these substances’ 
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structure (Deblonde et al., 2011; Fatta-Kassinos et al., 2011). Pharmaceutical residues 
in animal excretion from agriculture activities through surface runoff can be further ex-
posed to upper soil layer and surface water. They may continue accumulating in the soil 
layer or penetrating into the groundwater system through leaching (Jongbloed and Lenis, 
1998). Hospitals are another source of pharmaceutical discharge. As hospitals do not 
usually accommodate a sewage water treatment unit to immediately treat their effluent 
after discharge, a large amount of chemicals resulted from healthcare services are dis-
charged directly into the urban wastewater (aus der Beek et al., 2016). High concentra-
tion of various drugs has been found in hospitals’ sewage effluent (Orias F, Perrodin Y. 
2013).  
In general, municipal wastewater treatment plants (WWTPs), even with activated sludge 
process, are not well equipped to remove all complex pharmaceutical residues since 
most of them were built with the main goal of removing biodegradable carbon, nitrogen, 
phosphorus and microorganisms.  The removal rates are from less than 20 % up to more 
than 80 % for most chemicals (Weber et al., 2014). However, it is not complete removal; 
therefore, pharmaceuticals find their way into the receiving water bodies after the effluent 
has been discharged from the WWTPs. From there, they can be moved along to accu-
mulate in water bodies, soil, groundwater then drinking water and eventually living or-
ganisms. 
2.3 Eco-toxicology 
So far research has revealed that although the acute toxicity of pharmaceuticals within 
water bodies is insignificant due to very low concentration (ng/L level), their chronic tox-
icity may pose a threat to non-target aquatic species in the future (Enick et al., 2007). 
Pharmaceutical residues, difficult to biodegrade in the environment, can accumulate and 
be exposed to aquatic beings throughout a long period of time (sometimes their whole 
life cycle), which may cause undesirable side effects to the ecosystem function 
(Kümmerer, 2009). Presently, some compounds have already reached the concentration 
level of displaying chronic/acute toxicity effects, such as diclofenac, propranolol and 
fluoxetine (Fent et al., 2006). Some examples of the toxicity of pharmaceuticals are re-
ported in Table 2. However, more research and data are still required in the future in 
order to reach the final conclusion on the eco-toxicological aspect of pharmaceutical res-
idues (Santos et al., 2010). 
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Table 2. Examples of eco-toxicological effects of pharmaceutical pollutants 
Class Name Non-target   
organism 
Observed     
effects 
References 
Analge-
sics/anti-in-
flammatory 
Diclofenac Vultures Enormous de-
crease in num-
ber of vultures 
on the Indian 
subcontinent  
Oaks et 
al.,2004 
Rainbow trouts Damage of 
liver, kidney 
and gills 
Triebskorn et 
al., 2007 
Antibiotics Sulfadiazine Hazel  Effects on pho-
tosynthesis 
ability and leaf 
transpiration 
Michelini et al., 
2015  
Maize Effect on 
growth and 
yield 
Death at high 
concentration 
Michelini et al., 
2012 
Willow Effect on water 
uptake 
Stress at high 
concentration 
Enrofloxacin 
Ciprofloxacin 
Cyanobacte-
rium 
Duckweed 
Decrease 
growth 
Ebert et al., 
2011 
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Class Name Non-target   
organism 
Observed     
effects 
References 
Estrogen 17α-ethylny-
lestradiol 
 
Fathead min-
now 
Feminization 
of males leads 
to near extinc-
tion of the spe-
cies within the 
experimental 
lake 
Kidd et al., 
2007 
Antidepressant Fluoxetine Leopard frog Later tadpole 
development 
Foster et al., 
2010 
Anxiolytics Oxazepam European 
perch 
Change in 
habits 
Brodin et al., 
2013 
Veterinary par-
asiticide 
Ivermectin Dung fly 
Beetle 
Death of eggs 
and larvaes 
Liebig et 
al.,2010 
Antibiotic resistance is another concern regarding pharmaceuticals in aquatic environ-
ment. Antibiotics after consumed by humans and animals can lead to the development 
of bacteria which are resistant to those drugs in the gut. These bacteria can be released 
into the environment through excretion. Antimicrobial resistant genes can also be pro-
moted in the aquatic system when antibiotic traces are available. Afterwards, these 
genes can be passed on to pathogenic bacteria, making them to be more potent as they 
may become more resistant to current treatment (Kümmerer 2009). 
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3 Current efforts in pharmaceutical residues removal 
3.1 Pharmaceutical removal ability of municipal wastewater treatment plants (WWTPs) 
Overall, common WWTPs have limited ability to fully degrade complex pharmaceutical 
pollutants due to the fact that they are not built with the intention of removing these sub-
stances at the first place. Figure 3 presents the basic layout of a standard WWTP.  
 
Figure 3. Basic layout of a standard municipal WWTP (the McIlvaine Company) 
The wastewater treatment process composes of four main stages: pre-treatment, pri-
mary treatment, secondary treatment and tertiary treatment. First, the influent 
wastewater arrives from the sewage system and passes through the pre-treatment pro-
cess. During this process the influent undergoes physical screening by bar racks, fine 
screens and aerated chamber for grit and fat removal. Next, the water is mixed with 
coagulant chemicals and delivered to the sedimentation tanks, where the primary treat-
ment progresses (sedimentation process). Within the tanks, sludge settles towards the 
bottom and scraped out while fat/grease float to the surface and skimmed off.  This is 
followed by the secondary treatment step, in which primary removal of organic matter 
(dissolved and suspended) occurs. This aim can be achieved through multiple different 
systems for secondary treatment, being fixed-film or attached growth systems (e.g. trick-
ling filters, constructed wetlands and rotating biological contactors) or suspended growth 
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system (e.g. activated sludge and membrane biological reactors). The final step, tertiary 
treatment includes biological nutrient removal (nitrogen and phosphorus) and disinfec-
tion (reduces the majority of microorganisms) to further improve the water quality. Lastly, 
the water (WWTP effluent) is discharged into a receiving water body.       
The sludge after being separated from the water goes through the sludge treatment pro-
cess. The aim of this treatment is to reduce the amount of organic matter and microor-
ganisms in the sludge before disposal. Common employed technologies are anaerobic 
digestion, aerobic digestion composting and incineration. 
From influent throughout the whole treatment process to effluent, most pharmaceuticals 
are removed to a degree but mainly remain in the effluent with low concentrations. Table 
3 and figures 4-7 show the levels of drug in the water before and after the treatment 
procedure in µg/L. 
Table 3. Influent-Effluent from various WWTPs (average concentration in µg/L) (Refer-
ences: Verlicchi et al., (2012)) 
Types of pharma-
ceutical  
Compound name Average Influent 
concentration 
(µg/L) 
Average Effluent 
concentration 
(µg/L) 
Analgesics/Anti-in-
flammatories 
Acetaminophen 38.00 0.89 
Ibuprofen 37.00 3.60 
Tramadol 32.00 20.00 
Salicylic Acid 17.00 0.17 
5-Aminosalicylic 
acid 
14.00 0.64 
Dipyrone 14.00 4.90 
Codeine 6.90 1.70 
Naproxen 6.00 1.00 
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Aspirin 3.10 0.36 
Ketoprofen 1.10 0.36 
Ketorolac 1.10 0.42 
Mefenamic acid 1.10 0.63 
Diclofenac 1.00 0.80 
Indomethacin 0.47 0.21 
Hydrocodone 0.12 0.01 
Fenoprofen 0.05 0.02 
Propyphenazone 0.05 0.04 
Phenazone 0.04 0.16 
Dextropropoxy-
phene 
0.03 0.10 
Antibiotics Ofloxacin 5.10 0.45 
Sulfapyridine 3.30 0.33 
Cefalexin 3.20 0.13 
Erythromycin 1.80 0.73 
Ciprofloxacin 1.60 0.86 
Roxithromycin 1.50 0.50 
Clarithromycin 1.30 0.29 
Chloramphenicol 1.00 0.05 
Sulfamethoxazole 0.92 0.28 
Trimethoprim 0.76 0.36 
Cefaclor 0.74 0.01 
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Anti-diabetics Glibenclamide 8.70 No data 
Anti-hypertensives Hydrochlorothia-
zide 
3.90 3.30 
Diltiazem 0.70 0.12 
Beta-blockers Atenolol 4.50 3.70 
Sotalol 0.60 0.75 
Propranolol 0.32 0.17 
Metoprolol 0.24 0.32 
Diuretics Furosemide 2.40 0.66 
Bendroflumethia-
zide 
0.05 0.004 
Lipid-regulators Benzafibrate 3.50 0.90 
Gemfibrozil 2.40 0.93 
Pravastatin 0.49 0.02 
Azithromycin 0.40 0.16 
Metronidazole 0.36 0.25 
Tetracycline 0.33 0.14 
Amoxicillin 0.24 0.01 
Norfloxacin 0.23 0.06 
Sulfachloro-
pyridazine 
0.19 0.06 
Sulfathiazole  0.11 0.01 
Sulfadimethoxine 0.07 0.09 
Cefotaxime 0.014 0.02 
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Clofibric acid 0.22 0.21 
Fenofibric acid 0.21 0.11 
Psychiatric drugs Gabapentin 13.00 2.60 
Amitriptyline 3.10 0.14 
Carbamazepine 1.20 1.04 
Fluoxetine 0.54 0.24 
Receptor antago-
nist 
Cimetidine 4.10 3.50 
Famotidine 0.08 No data 
Loratadine 0.03 No data 
Omeprazole 0.85 0.63 
Ranitidine 2.70 0.51 
Valsartan 2.50 0.33 
Hormones/Estro-
gens 
Estradiol 0.25 0.01 
Estriol 0.17 0.016 
Estrone 0.08 0.03 
Ethinylestradiol 0.02 0.003 
Antiseptics Triclosan 1.90 0.32 
Contrast media Iopromide 2.20 2.50 
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Figure 4-1. Average concentration levels of analgesics and anti-inflammatories (in µg/L) 
before and after WWTP 
 
Figure 4-2. Average concentration levels of analgesics and anti-inflammatories (in µg/L) 
before and after WWTP (continued) 
0
5
10
15
20
25
30
35
40
C
o
n
c
e
n
tr
a
ti
o
n
 (
µ
g
/L
)
Influent
Effluent
0,00
0,20
0,40
0,60
0,80
1,00
1,20
C
o
n
c
e
n
tr
a
ti
o
n
 (
µ
g
/L
)
Influent
Effluent
17 
  
 
Figure 5-1. Average concentration levels of antibiotics (in µg/L) before and after WWTP 
 
Figure 5-2. Average concentration levels of antibiotics (in µg/L) before and after WWTP 
(continued) 
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Figure 6. Average concentration levels of anti-hypertensives / Beta-blockers / Diuretics / 
Lipid regulators / Psychiatric drugs (in µg/L) before and after WWTP 
 
Figure 7. Average concentration levels of receptor antagonist/Hormones/Antiseptic/Con-
trast media (in µg/L) before and after WWTP 
As observed from the data, WWTP’s process is mostly not successful in complete re-
moval of all pharmaceutical products, leaving small amount of each in the effluent which 
is discharged into the receiving water bodies. Additionally, some irregular trends can be 
seen: for some substances, their concentrations increase after undergoing wastewater 
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treatment (negative removal efficiency). The reason for this may be due to deconjugates 
intervening with biological conversion of deconjugated substances. Another reason 
could be that some particular pharmaceuticals which are sorped onto the particulate dis-
solving are released after the biological treatment phase. Lastly, this could be the result 
of instrumental errors when measuring pharmaceuticals with very low concentrations. 
(Verlicchi et al., 2012)  
Throughout the whole treatment process, the removal of residual drugs occurs during 
preliminary, primary treatment (by absorption onto solids and sedimentation) and sec-
ondary biological treatments (by biodegradation and absorption on to particles, flocs and 
sludge). The removal ability of preliminary and primary treatment has been noted by 
many to be poor (Khan and Ongerth, 2005; Yasojima et al., 2006; Watkinson et al., 2007; 
Zorita et al., 2009). Most drug compounds are present in aqueous phase, while having 
low sorption ability onto coarse solids and sludge (Ternes et al., 2004); therefore, it is 
reasonable to observe that the physical screening of the pre-treatment and the sedimen-
tation process fail to remove a significant amount of them. Sometimes pharmaceuticals 
may even be released during these steps due to the simultaneous presence of deconju-
gable substances of these substances in the influent (Göbel et al., 2005). Most notable 
for low removal percentage are ibuprofen and naproxen, with their quantity experienced 
little reduction during preliminary treatment and sedimentation; hormone estrone con-
centration was found to be increased at the end of primary treatment (Carballa et al., 
2004).     
The main mechanisms of removal during secondary treatment are biodegradation and 
sorption (absorption and adsorption). However, with the sorption ability onto sludge to 
be poor and low capacity for biodegradable (Jia et al., 2012), their removal seems to be 
due to the sorption onto flocs which are formed by hydrophobic and electrostatic inter-
actions of microorganisms (Lindberg et al., 2006; Jia et al., 2012). Overall, secondary 
treatment is generally more effective than pre-treatment and primary treatment in chem-
ical residue removal (Carballa et al., 2004). 
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3.1.1 Pharmaceutical removal efficiency of conventional wastewater treatment plants 
(WWTPs) 
Call P is the overall pharmaceuticals removal efficiency of WWTPs, assuming influent 
and effluent flowrate are constant throughout the day as well as concentration of phar-
maceuticals unchanged, P can be represented as followed: 
𝑃 =
𝐶in − 𝐶out
𝐶in
∗ 100  % 
P is the average removal efficiency 
Cin is the average concentration of a pharmaceutical in the influent 
Cout is the average concentration of a pharmaceutical in the effluent 
Removal efficiency P for all pharmaceuticals are presented in Figure 8-11. 
 
Figure 8. Average removal efficiency (P) of analgesics and anti-inflammatories (%) in 
common municipal WWTPs 
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Figure 9. Average removal efficiency (P) of antibiotics (%) in common municipal WWTPs 
 
Figure 10. Average removal efficiency (P) of anti-hypertensives/beta-blockers/diuret-
ics/lipid regulators/psychiatric drugs (%) in common municipal WWTPs 
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Figure 11. Average removal efficiency (P) of receptor antagonist/hormones/antisep-
tic/contrast media (%) in common municipal WWTPs 
As these charts depicts, the removal efficiencies for pharmaceutical products vary widely 
from less than 20 % to more than 90 %. Some cases show even up to 99 % removal 
rate. Some pharmaceuticals show good record for example salicylic acid, acetamino-
phen, 5-aminosalicyclic acid, hydrocodone, ibuprofen (analgesics/anti-inflammatories), 
cefaclor, cefalexin, amoxicillin, ofloxacin, chloramphenicol, sulfathiazole, sulfapyridine 
(antibiotics), bendroflumethiazide, pravastatin, amitriptyline, estradiol, estriol (other 
groups) with  high removal rate (90 % and higher). Some of the poor efficiency marks 
are diclofenac, propyphenazone (analgesics/anti-inflammatories), hydrochlorothiazide, 
atenolol, clofibric acid, carbamazepine, cimetidine (other groups) with insignificant re-
moval volume (20 % and less). While common municipal WWTPs show good prowess 
in removing some chemicals with more than 90 % of their original amount, it should be 
noted that very low loads of these still get released into the environment daily and can 
accumulate with time, considering typical municipal WWTPs release thousands cubic 
meter of effluent daily.    
In conclusion, pharmaceutical residues compose of a great variety of compounds, many 
different chemical and physical characteristics and react differently under the same cir-
cumstance. Therefore, more complex, well-rounded and specified treatments must be 
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utilized within WWTPs to successfully remove the majority if not all of the residual sub-
stances. Currently, there are several technologies employed specifically for chemicals 
removal, their pros and cons will be discussed in the next section. 
3.2 Current pharmaceutical removal technologies 
3.2.1 Adsorption on activated carbon 
3.2.1.1 Overview 
Activated carbon is a form of processed carbon with high quantity of small, low volume 
pores which increase the overall surface area for adsorption. Further chemical treatment 
of carbon can further enhance adsorption capacity. Activated carbon usage in pharma-
ceuticals removal has been reported by several literatures to be effective with high ca-
pacity for pollutants adsorption. (Snyder et al., 2007; Choi et al., 2008; Kårelid et al., 
2017). There are several types of activated carbon; however, only two main types are 
studied extensively for pharmaceuticals adsorption: powdered activated carbon (PAC) 
and granular activated carbon (GAC). PAC is characterized as fine granules with less 
than 1 mm in size and average diameter between 0.15 and 0.25 mm. GAC mainly differs 
from PAC that it has larger grain size, which is typically in range of 1.2 to 1.6 mm. Both 
types of activated carbon can be prepared from charcoal or natural high carbon content 
sources such as bamboo, wood and coconut husk. These materials are heated slowly in 
oxygen-free environment at above 400 °C (carbonization phase), then treated with oxi-
dizing agent (steam or carbon dioxide is commonly utilized) at high temperature to create 
the submicroscopic spores and increase surface area (activation phase). For example, 
Mestre et al.,2007 reported using cork powder waste to produce activated carbon by 
mixing the waste with K2CO3 (weight ratio 1:1) and heating at 700 °C for 1 h. The sample 
was then let to be cool down then washed with distilled water until pH is 7 and dried at 
100 °C. To finish, the sample is activated using steam at 750 °C for an hour.   
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3.2.1.2 Operating mechanism 
Activated carbon removes chemicals from water by mechanism called adsorption. It is 
the adhesion of dissolved chemical molecules (adsorbate) to the surface of activated 
carbon (adsorbent), which creates a film of adsorbate on it. When introduced into the 
water, carbon molecules actively seek out other molecules they can adsorb. With high 
surface area and porous nature activated carbon has good capacity for chemical adsorp-
tion. 
 
3.2.1.3 Factors affecting performance 
There are several factors influencing the effectiveness of activated carbon adsorption: 
 Ingredients types and production methods affect adsorption capacity (i.e. differ-
ent materials and different treatment procedures can create activated carbon with 
different adsorption capacity). 
 Contact time: the longer the exposure time, the more drug residues activated 
carbon can adsorb (until it reaches capacity limit). 
 The amount of carbon in the system: More activated carbon molecules means 
more residues could be removed  
 Surface area: For example, powdered activated carbon (PAC) is considered to 
give better results with regard to carbon consumption compared to the granular 
form (GAC) due to the larger surface area of the finer grains (Meinel et al., 2015). 
 Temperature: temperature between 5 to 40 °C does not seem to affect the effec-
tiveness of activated carbon in pharmaceuticals removal. Mestre et al., 2007 and 
Baccar et al., 2012 showed that temperatures range 25–40 °C has insignificant 
influence on the adsorption process onto powder activated carbon. Villaescusa 
et al., 2011 also noted that the temperature between 5 and 30 °C has negligible 
influence on paracetamol sorption onto activated carbon made from grape stalk.  
 pH: Increase in pH reduces the uptake of drug compounds, and this effect is even 
more noticeable when the pH becomes high (alkaline region). For example, Bac-
car et al., 2012 reported gradual decrease in removal efficiency of Diclofenac, 
Naproxen, Ketoprofen and Ibuprofen in activated carbon adsorption system when 
pH increases from 2 to 8.61. Similarly, Cho et al., 2011 and Bhera et al., 2010 
also noticed a reduction in activated carbon effectiveness when increasing pH 
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level from 3 to 10 in an activated carbon utilization (for removing ibuprofen and 
triclosan, respectively). 
 Hydrophobicity (log Kow): Westerhoff et al., 2005 concluded that compounds with 
low log Kow seem to be more challenging to adsorp with powder activated carbon 
(PAC). For example, diclofenac and naproxen have the same pKa, but diclofenac 
is adsorbed better due to higher hydrophobicity (diclofenac’s log Kow = 4.51 and 
naproxen’s log Kow = 3.18). 
 Availability of natural organic matters: activated carbon’s performance decreases 
significantly when the amount of natural organic matters within the water is high, 
due to the fact that these matters competes with pharmaceuticals for binding 
sides and thereby block available spores for adsorption of target compounds (Luo 
et al., 2014). 
 
3.2.1.4 Advantages and limitations of using activated carbon 
Activated carbon treatment has several advantages as well as limitations as follows: 
Advantages: 
 Activated carbon does not generate toxic or pharmacologically active products 
during the introduction into water as well as the adsorption process.  
 Environmental friendly. Activated carbon production can employ recycling mate-
rials (coconut husk, biomass residues,etc…) 
 Less complicated setting and operation 
 High removal rate of several common pharmaceuticals from wastewater such as 
Atenolol, Carbamazepine, Diclofenac, Trimethroprim, Triclosan, Fluoxetine.  (As 
shown in table 4) 
Limitations: 
 Total energy demand for application with activated carbon is considerably higher 
(Mousel et al., 2017). Therefore, the cost of utilizing activated carbon for 
wastewater treatment is high. 
26 
  
 There is a need for regular regeneration or disposal of used activated carbon to 
sustain high removal efficiency, which adds more overall cost. 
3.2.1.5 Removal efficiency 
Table 4 demonstrates the removal rate of several popular pharmaceutical drugs in 
wastewater using powdered and granular activated carbon. Overall, activated carbon 
treatment is able to remove a wide range of pharmaceutical pollutants with high success. 
For example, Kårelid et al., 2017 tested the effectiveness of both PAC and GAC in a 
wastewater treatment plant scenario and reported a removal rate of over 95 % (for PAC) 
and over 90 % (for GAC) for all 22 tested compounds, including commonly found sub-
stances such as carbamazepine, clarithromycin and diclofenac. The dosage of 15-20 
mg/L for PAC is proved to be sufficient to achieve such results. Additionally, within the 
dosage range of 30-100 mg/L, PAC was found to produce better performance than GAC 
(with the exception of atenolol, clarithromycin and metoprolol). The overall effectiveness 
of PAC can be comparable with that of ozone treatment (Luo et al., 2014). 
 
Table 4. Removal rate of several popular pharmaceutical drugs in wastewater using ac-
tivated carbon (PAC and GAC). 
Adsorbent Pharmaceutical(s) Removal efficiency 
or adsorption ca-
pacity 
References 
GAC Trimethoprim 118-345 mg/g Liu et al.,(2012) 
GAC Ibuprofen 
Ketoprofen 
Naproxen 
Diclofenac 
12.6 mg/g 
24.7 mg/g 
39.5 mg/g 
56.2 mg/g 
Baccar et al.,(2012) 
GAC Paracetamol 113-267 mg/g Cabrita et al.,(2010) 
GAC Ciprofloxacin 119-320 mg/g Carabineiro et 
al.,(2011) 
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Adsorbent Pharmaceutical(s) Removal efficiency 
or adsorption ca-
pacity 
References 
GAC 
PAC 
Trimethoprim 257.9 mg/g Kim et al.,(2010) 
GAC Paracetamol 
Ibuprofen 
119.1-151.9 mg/g 
121.2-166.3 mg/g 
Mestre et al.,(2011) 
GAC Tetracycline 95 % Choi et al.,(2008b) 
PAC Ibuprofen 
Iopromide 
Sulfamethoxazole 
Gemfibrozil 
Diclofenac 
Naproxen 
16-30 % 
30-50 % 
36-56 % 
37-55 % 
38-46 % 
52-58 % 
Snyder et al.,(2007) 
GAC Acetaminophen 
Carbamazepine 
Trimethoprim 
Triclosan 
Fluoxetine 
73-84 % 
74-86 % 
76-96 % 
90-96 % 
91-92 % 
Snyder et al.,(2007) 
PAC and GAC Atenolol 
Carbamazepine 
Diclofenac 
Trimethroprim 
99 % 
94-95 % 
97-99 % 
98-99 % 
Kårelid et al., 2017 
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3.2.2 Advance oxidation process and photocatalytic process using Ultraviolet radiation 
(UV) 
3.2.2.1 Overview 
Ultraviolet (UV) is an invisible electromagnetic radiation with frequency higher than visi-
ble light - lower than x-rays and wavelength in the region of 10 nm – 400 nm. UV is 
present naturally in sunlight and has high energy. UV light has long been known for its 
effective disinfection ability: it penetrates harmful pathogens in water and destroy micro-
organisms’ DNA and RNA, hence eliminating their reproductive ability. UV can disinfect 
very efficiently with up to 99 % harmful microorganisms with very simple set up and with-
out chemical addition that affects water quality and taste. Therefore, UV radiation sys-
tems are already commonly used in water treatment plants during the tertiary treatment 
phase for water disinfection. In water treatment, UV radiation are employed at the wave-
length range of 250 nm – 270 nm, with the most frequently used wavelength being 
254 nm. Recently, UV light has also been discovered for its utility in pharmaceuticals 
degradation (Lazarova and Savoye, 2004). Main applications of UV light in pharmaceu-
ticals removal are UV, UV/H2O2, UV/H2O2/Fe2+, UV/TiO2. UV usage alone is direct pho-
tolysis process where UV cause the degradation in organic compounds that are able to 
absorb UV photons (usually at 254 nm wavelength). UV/H2O2, UV/H2O2/Fe2+ are ad-
vance oxidation processes which utilize hydroxyl radicals (∙OH) as another oxidation 
pathway to degrade organic compounds. UV/TiO2 is a photocatalytic process, where 
TiO2 acts as a semiconductor material which upon UV radiation produces hydroxyl radi-
cals, in the end works similar to advance oxidation process. 
3.2.2.2 Operating mechanism 
Two main pathways of UV technology are the direct photolysis under UV radiation expo-
sure and oxidation process created by hydroxyl radicals. Direct photolysis is the process 
when compounds absorb UV photons, increasing its energy to reach an excited state, 
leading to bond breaking and degradation. The substance structure is the main determi-
nant of whether that substance is able to absorb UV energy. Many pharmaceutical prod-
ucts are photoactive (i.e. they can absorb UV photons), hence photodegradable. Never-
theless, the photolysis process produces several unwanted side products which are also 
highly toxic. Drug residues which do not go through direct photolysis can degrade 
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through another pathway: under the effect of hydroxyl radicals’ reaction. Hydroxyl radi-
cals are produced from the photolytic dissociation of additional reagents (most commonly 
H2O2) under UV exposure. In UV/TiO2 photocatalytic process, hydroxyl radicals are pro-
duced through the reduction of oxygen and water by electron-hole pairs, created when 
the semiconductor TiO2 is exposed to UV radiation. Additionally, they can also be gen-
erated in a photo-Fenton system (UV/H2O2/Fe2+), where not only the UV + H2O2 interac-
tion makes radicals but also the H2O2 + Fe2+ and UV + Fe2+ reactions. Hydroxyls radicals 
reacts unselectively with many pharmaceutical residues to break down those com-
pounds and also destroy many toxic side products of UV photolysis. However, it also 
affects radicals performance as many other micropollutants are present in WWTPs ef-
fluent, which can also reacts with hydroxyls radicals, making less available for the deg-
radation of main priority targets. 
Equations: 
𝐻2𝑂2 + 𝑈𝑉 → 2 ∙ 𝑂𝐻              (hydroxyl radicals generated by UV radiation) 
𝐹𝑒2+ + 𝐻2𝑂2 → 𝐹𝑒
3+𝑂𝐻 ∙ +𝑂𝐻−     (hydroxyl radicals generated by Fenton process) 
𝐹𝑒3+ + 𝐻2𝑂2 → 𝐹𝑒
2+ + 𝐻𝑂2 ∙ +𝐻
+  (Fe(III) reverts to Fe(II) to continue the hydroxyl radi-
cals generation cycle) 
 
3.2.2.3 Factors affecting performance 
There are several factors influencing the effectiveness of advanced oxidation process 
using UV: 
 pH affects the generation of hydroxyl radicals (alkaline pH level is favored) 
 The chemical structure of the target pharmaceutical determines if that pharma-
ceutical could absorb UV photons to degrade or not. 
 A large number of suspended particles makes UV light less effective because it 
prevents the penetration of UV light into the water. 
 The amount of additional chemicals (H2O2 or Fenton’s reagent) affects the quan-
tity of available hydroxyl radicals for degradation. 
 The availability of interfering radicals which react with hydroxyl radicals reduces 
the amount available to degrade target compounds. 
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3.2.2.4 Advantages and limitations of UV techniques 
UV treatment has several advantages as well as limitations as follows:  
Advantages: 
 UV techniques are less affected by drastic pH and temperature change compared 
to other technologies. 
 UV radiation is already used widely in WWTPs for disinfection.  
 UV techniques are simple set up and usage. 
 UV treatment is cost-effective and highly sustainable (relatively low cost equip-
ment, low energy input and cheap chemical reagents addition). 
 
Limitations: 
 UV radiation can only work efficiently on clear water, murky water affects the UV 
ray ability to infiltrate the whole water body and reduces its effectiveness. 
 The addition of H2O2 is frequently needed to maximize the treatment efficacy, 
since UV light alone is not able to degrade a wide variety of drug residues. 
 Photodegradation process of some pharmaceutical compounds produces highly 
toxic side products. 
3.2.2.5 Removal efficiency 
Table 5 demonstrates the removal efficiency for various pollutants utilizing several com-
mon UV technologies. Generally, UV is not particularly a great treatment method when 
applied alone as it can only remove a few pharmaceuticals with significant effectiveness 
(>90 % removal rates for those such as tetracycline, ketoprofen,diclofenac and antipy-
rine) (Kim et al., 2009; Gomez-Pacheco et al., 2012). The capability of UV treatment is 
improved greatly when used in conjunction with H2O2, Fenton’s reagent or TiO2 which 
boost the generation of hydroxyl radicals. For instance, in a study conducted by Kim et 
al., (2009) which examined the effect of 254 nm UV/ H2O2 combination in the elimination 
of 41 pharmaceutical compounds found that the addition of 7.8 mg/L H2O2 increases the 
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efficacy of the UV treatment greatly from >90 % removal of a few substances to >90 % 
removal of 39 pollutants. Another research by De la Cruz et al., (2012) which investigated 
difference between 254 nm UV alone and the combination of 254 nm UV and Fenton’s 
reagent (Fe2 +,3 +/H2O2) also confirmed a similar conclusion. Out of 32 targeted micropol-
lutants, UV standalone treatment could only degrade successfully diclofenac, keto-
profen, mefenamic acid with 100 % amount while showing low results on others. Mean-
while, the mix of UV and 50 mg/L H2O2 produced a total degradation rate of 81 %, which 
was further increased to 97 % after another 30 minutes of treatment. Similarly, the 
Fe2 +,3 +/H2O2/UV combo generated an appealing result as a global degradation of 97 % 
was observed. 
 
Table 5. Removal efficiency of several UV technologies 
Treatment 
method 
Target pollutant Removal effi-
ciency 
References 
UV Metronidazole 83 % Prados-Joya et al., 
(2011) 
 Dimetridazole 82 % 
 Tinidazole 76 % 
 Ronidazole 73 % 
 Carbamazepin <5 % Lekkerkerker-Teunis-
sen et al., (2012) 
 Tetracycline 100 % Gomez-Pacheco et 
al.,(2012) 
UV/H2O2 Doxycycline 100 % Andreozzi et al.,(2004) 
 Ciprofloxacin 
 Diclofenac 100 % Andreozzi et al.,(2004) 
 Amoxicillin 99 % Jung et al.,(2012) 
 Carbamazepine 100 % Andreozzi et al.,(2004) 
 Ofloxacin 100 % Andreozzi et al.,(2004) 
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Treatment 
method 
Target pollutant Removal effi-
ciency 
References 
UV/TiO2 (with 
and without 
H2O2) 
Atenolol 100 %  Yang et al., 2010 
 Metoprolol 
 Propranolol 
 Amoxicillin 100 % with 
H2O2 and much 
lower without 
Elmolla and Chaudhuri 
(2010) 
 Ampicillin 
 Cloxacillin 
UV/H2O2/Fe2+ Carbamazepine 100 % De la Cruz et al ., 2012 
 Diclofenac 
 Ibuprofen 
 Ketoprofen 
 Naproxen 
 Ciprofloxacin 
 
3.2.3 Ozonation (O3) 
3.2.3.1 Overview 
Ozone is a molecule that consists of three oxygen atoms (O3). It is basically the normal 
atmospheric oxygen (O2) with an additional oxygen atom attached by a weak bond. This 
weak bond makes ozone unstable under normal conditions and readily revertible to O2 
which is the more stable form. This also gives ozone a high oxidizing power with various 
kinds of organic compounds and microorganisms, especially those with electron-rich 
functional groups such as double bonds or aromatic rings. Therefore, ozonation is widely 
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utilized in drinking water treatment in order to disinfect, remove inorganic materials and 
eliminate odor/taste. Recently, with the increased awareness of pharmaceutical residues 
in water, ozone has been tested for the ability to decompose these harmful substances. 
It has been reported that ozonation is a promising post treatment as it significantly re-
duces pharmaceutical load in a full scale WWTP, with a relatively low dose and high 
efficiency (Hollender et al., 2009). This method has been shown to be able to remove a 
wide range of pharmaceutical residues with a high removal rate up to 90-100 % (Sui et 
al., 2010; Gerrity et al., 2011). However, ozonation is not without drawbacks. Ozone is 
not very effective in oxidizing some popular pharmaceuticals such as perindopril, phen-
ytoin, sertraline or ketoprofen (Ahmed et al., 2017)  Furthermore, research has indicated 
the formation of the potentially carcinogenic substances such as bromate and N-nitro-
sodimethylamine (NDMA) can be facilitated with ozone usage and reduce overall water 
quality (von Gunten 2003, Hollender et al., 2009; Yang et al., 2009). The ozone system 
also consumes a high amount of energy and thereby has high operating cost: Ahmed et 
al., 2017 studied and reported that an ozone treatment system can boost the energy 
consumption in a common sewage treatment plant by 40–50 %. Overall, despite of its 
limitations, ozonation is currently still a very viable option to remove unwanted micropol-
lutants with high efficiency and restore the water quality.  
3.2.3.2 Operating mechanism 
There are two main mechanisms operating the oxidation of organic compounds in ozo-
nation process: the direct pathway in which ozone reacts directly with the contaminants 
and the indirect pathway in which ozone decomposes to create hydroxyl radicals (∙OH), 
which react non-selectively with organic molecules. H2O2, Fenton reagent and ultraviolet 
are frequently used in combination with ozone as they promote the generation of OH 
radicals.  
Generation of hydroxyl radicals by ozone can be expressed as follows: 
𝑂3 + 𝑂𝐻
−  → 𝐻𝑂2
− + 𝑂2 
𝑂3 + 𝐻𝑂2
− → 𝐻𝑂2 ∙  + 𝑂3
− ∙ 
𝑂3
− ∙ +𝐻+ → 𝐻𝑂3 ∙  
𝐻𝑂3 ∙→ 𝑂𝐻 ∙ +𝑂2 
Generation of hydroxyl radicals by the addition of Fe(II) and H2O2 can be expressed as 
follows: 
𝐹𝑒2+ + 𝐻2𝑂2 → 𝐹𝑒
3+𝑂𝐻 ∙ +𝑂𝐻− 
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𝐹𝑒3+ + 𝐻2𝑂2 → 𝐹𝑒
2+ + 𝐻𝑂2 ∙ +𝐻
+ 
 
Some organic compounds readily react to ozone through both mechanisms (naproxen 
and carbamazepine); some only react to OH radicals and not to ozone directly (atrazine 
and meprobamate) and some are resistant to both forms of oxidation (e.g. tris(2-carbox-
yethyl)phosphine and tris(2-chloroisopropyl)phosphate) (Gerrity et al., 2011). Overall, 
molecular ozone can only react selectively with organic substances (such as those with 
electron-rich functional groups) and this direct pathway has smaller reaction rates, while 
OH radicals are not discriminating; therefore, the reaction rates are much faster. 
3.2.3.3 Factors affecting performance 
There are several factors influencing the effectiveness of ozone treatment: 
 Dosage: Antoniou et al., (2013) tested the effectiveness of ozone in removing 42 
different pharmaceuticals and showed that a dosage of 1.4 g O3 per g DOC (dis-
solved organic carbon) is required to achieve a removal rate of at least 90 %. For 
chemicals that are resistant to ozone treatment, a double amount (2.8 g O3 per g 
DOC) is required, thus increase the cost of treatment significantly. 
 pH: It has been proved that even though the formation of hydroxyl radicals is 
enhanced under alkaline conditions, lower pH is beneficial for overall pharma-
ceuticals removal efficiency (Zhang et al. 2012).  
 Interfering ions: some ions (such as bromate (Br -)) can interfere with the ozona-
tion process. 
 Wastewater composition: suspended particles in the wastewater may also react 
with ozone, decreasing the amount available for the degradation of pharmaceu-
ticals. Therefore, wastewater with high amount of suspended particles may need 
a higher amount of ozone. However, this effect seems to be minor (Hernández-
Leal et al., 2011; Huber et al., 2003) 
 Chemical structure of pollutants: Since ozone readily reacts with electron-rich 
functional groups, the chemical structure of pharmaceuticals available in the 
wastewater (whether it has the electron-rich functional groups) determine if the 
pharmaceutical would be effectively degraded by O3. Positive functional groups 
for degradation are C-C double bonds, tertiary amines, aniline, phenol and meth-
oxy groups. Meanwhile, electron-withdrawing functional groups, such as fluoro, 
nitro, chloro, amide and carboxyl, prevent direct oxidation reactions from ozone 
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(Nakada et al., 2007; Hollender et al., 2009; Antoniou et al., 2013). Additionally, 
pollutants that are resistant to ozone’s direct oxidation may still be degraded 
through the hydroxyl radical pathway.  
3.2.3.4 Advantages and limitations 
Ozone treatment has several advantages as well as limitations as follows: 
Advantages: 
 Capable of removing a wide range of pharmaceuticals in a relatively short time 
duration 
 Very effective, offering a high removal rate of pharmaceutical residues (>90 %) 
Limitations: 
 High energy consumption 
 Formation of carcinogenic by-products such as bromate, N-Nitrosodimethyla-
mine (NDMA) (von Gunten 2003; Hollender et al., 2009; Yang et al., 2009) 
 Interference of radical scavengers 
3.2.3.5 Removal efficiency 
Table 6 shows the removal efficiencies for several commonly found pharmaceuticals us-
ing ozone technologies. Overall, ozone treatment is capable of breaking down a large 
variety of micropollutants within the wastewater with high efficiency. Sui et al., (2010) 
studied the application of ozone in treating pharmaceutical residues within four WWTPs’ 
effluent. An ozone dose of 5 mg/L was shown to decrease the concentrations of carbam-
azepine, diclofenac, indomethacin, sulpiride and trimethoprim by more than 95 %. How-
ever, the reduction of N, N-Diethyl-meta-toluamide (DEET), metoprolol and bezafibrate 
was only moderate, especially bezafibrate (removal rate of 14 %). Similarly, another 
study conducted by Gerrity et al., (2011) showed that the application of ozone/ H2O2 
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combination can produce a respectable performance with > 90 % for 17 target contami-
nants including carbamazepine, diethyltoluamide (DEET), diclofenac and fluoxetine. Me-
probamate (80 %) and ibuprofen (83 %) also were removed by an acceptable amount. 
However, TCEP (13 %), TCPP (26 %) and atrazine (69 %) was proved to be more re-
sistant to this type of treatment. 
 
Table 6. Removal efficiency of ozone treatment towards various target compounds 
Treatment Targeted com-
pounds 
Removal (%) Reference 
O3 (5 mg/L) for 15 
min 
Carbamazepine >90 Sui et al., 2010 
Diclofenac >90 
Metoprolol 80-90 
Bezafibrate 0-50 
Trimethoprim >90 
O3 (5 mg/L) + H2O2 
(3.5 mg/L) 
Ibuprofen 83 Gerrity et al., 2011 
Diclofenac >99 
Carbamazepine >99 
Sulfamethoxazole 98 
Triclosan >99 
Estradiol >83 
Estrone >98 
 
3.2.4 Biological based treatment    
3.2.4.1 Overview 
Recently, biological-based water treatment technologies have emerged and gained con-
siderable attention. These types of treatment utilize natural ingredients such as fungi, 
microalgae or macrophyte species, simulating the ability of natural ecosystems to mini-
mize the effect of micropollutants. There are some significant benefits of these treatment 
methods compared to other advanced treatments such as lower overall cost, less toxic 
side products, production of ecology-rich water effluent and biomass for biofuel produc-
tion. Several setups are available as biological-based treatment including high-rate algal 
ponds (using microalgae), constructed wetlands (using macrophytes), fungal reactors 
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(using fungi). Several studies have shown a trend of high effectiveness of these methods 
in removing pharmaceutical residues (Rodríguez-Rodríguez et al., 2012; Ávila et al., 
2013; Garcia-rodríguez et al., 2013; Matamoros et al., 2015). Overall, biological-based 
treatments are promising solution for the future of micropollutants removal due to the 
competitive edges and versatility they bring. Table 7 demonstrates the main features of 
several biological treatments.  
Table 7. Description of several biological-based wastewater treatment technologies     
Treat-
ment 
name  
Ingredients Description Main mechanisms 
involved 
High-
rate algal 
ponds 
Microalgae 
(Stigeoclo-
nium sp., dia-
toms, Chlo-
rella sp.) and 
heterotrophic 
bacteria  
Passos et al., (2014:351) described 
the high-rate algal ponds as “shallow 
raceway reactors in which microalgae 
and bacteria grow in symbiosis”. 
Within the systems, heterotrophic 
bacteria degrade organic matter and 
expend oxygen provided by microal-
gal photosynthesis activity; thus, no 
aeration is required. 
Phytoremediation 
 
Con-
structed 
wetlands 
Macrophytes 
(Phragmite 
australis, 
Typha an-
gustifolia) 
 
Constructed wetlands utilize shallow 
ponds, beds containing floating or 
emergent rooted wetland vegetation, 
which wastewater runs through. Mi-
crocontaminants are removed either 
by plant uptake, photodegradation or 
biodegradation (by rhizosphere mi-
crobial community) (Garcia-
Rodríguez et al., 2013)  
Phytoremediation 
Biodegradation 
Photodegradation 
Sorption 
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Treat-
ment 
name  
Ingredients Description Main mechanisms 
involved 
Fungal 
reactors 
White-rot 
fungi  
(Phanero-
chaete chrys-
osporium, 
Trametes ver-
sicolor) 
White-rot fungi species excrete oxida-
tive enzymes that are able to degrade 
a wide variety of organic pollutants. 
Fungal treatment can be used in 
packed bed bioreactor, fluidized bed 
bioreactor, trickle-bed bioreactor, 
stirred tank bioreactor, rotating biolog-
ical contactor, and membrane biore-
actor.  
Biodegradation 
 
3.2.4.2 Operating mechanisms 
There are several mechanisms involved in biological-based treatments depending on the 
set-up and the materials used. Dominant mechanisms are as follows: 
 Biodegradation is the process in which microorganisms such as bacteria and 
fungi produce enzymes which are responsible for the decomposition organic pol-
lutants into simpler chemical substances which pose no harm to the environment 
(Cajthaml et al., 2009). The process can be performed under aerobic or anaero-
bic conditions.  
 Phytoremediation is the direct use of living plants (macrophytes and algae) to 
remove hazardous chemicals. It can occur through plant uptake, plant exudates 
or enzymes produced by plants that break down chemical substances or with the 
participation of rhizosphere organisms (i.e. microorganisms within the region of 
soil that is directly influenced by root secretions) (Pilon-Smits 2005; Susarla et al. 
2002). 
39 
  
 Photodegradation does not involve plants but the effect of sun ray. Some chem-
icals that can be difficult to break down under other process (i.e. diclofenac and 
triclosan), are decomposed under the effect of solar energy. Photodegradation 
composes of direct and indirect pathway. Direct photodegradation involves the 
absorption of solar energy by chemical pollutants, which in turn enter the se-
quence of chemical reactions, which break them down into simpler substances. 
Indirect photodegradation is the pathway in which pollutants are broke down by 
the high oxidizing power of hydroxyl radicals generated by the effect of radiation.    
 Sorption includes absorption and adsorption. Adsorption is the process in which 
the pollutants are adhered physically onto the surface of a sorbent. Absorption is 
the incorporation of the contaminants into the sorbent. 
3.2.4.3 Factors affecting performance 
There are several factors influencing the effectiveness of biological treatment: 
 Hydraulic retention time (HRT): Matamoros et al., (2013) have shown that phar-
maceuticals removal rates in biological-based treatment systems increases with 
longer HRT due to the fact that biodegradation and sorption processes have more 
time to function.  
 pH: The appropriate pH level has a positive impact on the optimal development 
and function of plants and microbial community.  
 Sunlight and temperature (or seasonal factors): The amount of sunlight and tem-
perature level affect plants and microbial development. These factors also di-
rectly influence algal and microbial activity. Research has shown that algal activ-
ity was clearly higher in summer than in winter, when the temperature is better 
suited, whereas average microalgal biomass concentration and production were 
noticeably better in hot seasons due to the higher amount solar radiation expo-
sure (Matamoros et al., 2015). 
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 Dissolved particles and suspended particles: A high amount of dissolved particles 
and suspended particles reduces sunlight penetration in water. Therefore, it af-
fects the effectiveness of photodegradation as well as the growth of algae (Gar-
cia-Rodríguez et al., 2013). 
 Micropollutants’ properties and their interaction with the plant system: Micropol-
lutants’ properties affect phytoremediation mechanism. Different types of plants 
can uptake a different range of micropollutants. Also, only certain chemicals with 
fitting structure, appropriate solubility, polarity, and partitioning coefficients can 
be uptaken by plants (Tsao 2003). 
3.2.4.4 Advantages and limitations 
Biological treatment has several advantages as well as limitations as follows: 
Advantages: 
 Overall cost-effectiveness and sustainablity: low energy consumption, low 
maintenance and operation cost. 
 Recovery of biomass for other purposes, such as biofuel production or fertilizing.  
 Production of high quality and ecology-rich effluent. 
Limitations: 
 Plants’ development as well as microbial activity are affected by seasonal varia-
bles such as temperature, sunlight intensity and duration. Therefore, there is a 
noticeable decline in the percentage removal rate in the cold season (Matamoros 
et al., 2015). 
 Biological-based treatments can remove a wide range of pharmaceutical pollu-
tants, but they are not particularly effective in removing some substances which 
resist these treatments. For example, high-rate algal ponds remove poorly 
(<30 % removal rate) carbamazepine or benzothiazole (Matamoros et al., 2015). 
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3.2.4.5 Removal efficiency 
Overall, the ability of biological based treatment to degrade unwanted pharmaceutical 
residues seems very promising. Fungal reactors are capable of degrading some com-
monly found chemicals such as codeine, atendol, propranolol, sotalol, acetaminophen, 
erythromycin, sulfathazole, sulfapyridine and sulfamethazine with up to complete re-
moval rate. The fungi based treatment system seems to remove betablockers at the 
highest effectiveness, followed by gastroesophageal, anti-inflammatory and stimulants, 
antibiotics, analgesics and lastly lipid regulators (Ahmed et al., 2017). 
Macrophytes-based treatment applied in constructed wetland also produces good re-
sults. For example, diclofenac, ibuprofen, and naproxen can be completely removed. 
However, some pharmaceuticals such as carbamazepine, clofibric acid, amoxicillin, clar-
ithormycin are resistant to this method and must be removed by different technology 
(Hijosa-Valsero et al., 2011; Garcia-Rodríguez et al., 2013). 
Microalgae-based treatment, most notably the high rate algal ponds (HRAPs), has been 
shown to be excellent in degrading caffeine, acetaminophen, ibuprofen and hydrocin-
namic acid with an overall removal rate of >90 % in a study by Matamoros et al., (2015). 
HRAPs also showed moderate success in removing ketoprofen, 5-methyl/benzotriazole, 
naproxen and triclosan (60 % to 90 % removal) but proved to be ineffective at treating 
carbamazepine, benzothiazole and tris(2-chloroethyl) phosphate (TCEP). Table 8 pre-
sents the pharmaceutical removal efficiency of some biological treatments. 
 
Table 8. Removal efficiency of various biological-based wastewater treatment methods 
Type of 
treatment 
Targeted phar-
maceuticals 
Removal rate (%) References 
Microalgae-
based 
Caffeine 98 Matamoros et al., 2015 
 Triclosan 95 
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 Acetaminophen 99 
 Ketoprofen 95 
Fungi-based Codeine 100 Garcia-rodríguez et al., 2013 
 Ibuprofen  92 
 Sotalol 100 Rodríguez-Rodríguez et al., 
2012 
 Atendol 100 Rodríguez-Rodríguez et al., 
2012 
Macrophytes 
based 
Ibuprofen 85 
Ávila et al., 2013 
 
 Acetaminophen  >95 
 Tetracycline 94 Carvalho et al., 2013 
 Naproxen 99 Ávila et al., 2010 
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3.3 Discussion 
Although considerable efforts has been put in discovering and testing different technol-
ogies to remove unwanted pharmaceutical residues and to restore the water quality, and 
while these methods have yielded results, they have yet to become perfect and limita-
tions are present. Not one technology is able to remove every pharmaceutical substance 
with great effectiveness, and each technology has a certain group of pharmaceuticals 
that are resistant to it. Furthermore, some treatment methods were shown to produce 
serious downsides which cannot be ignored (the production of highly toxic side products 
such as carcinogenic bromate substance in ozonation, for example). In order to minimize 
the disadvantages and maximize the effectiveness of these technologies, coupling treat-
ments was suggested. For instance, advance oxidation method (UV or ozone) can be 
paired with activated carbon so as to improve the global degradation ability, as activated 
carbon can control some substances that ozonation cannot and vice versa. Additionally, 
activated carbon can help collect toxic side products formed from oxidation process 
(Sánchez-Polo et al., 2008). 
4 Conclusion 
Pharmaceutical residues have emerged and attracted considerable attention recently as 
potentially hazardous pollutants to the environment.  There is evidence showing traces 
of these micropollutants in water resources and wastewater treatment plants’ effluent 
across the globe. Even though their concentrations are low (in the ng/L to μg/L range), if 
left unchecked and allowed to accumulate over the years, this chemical waste can pose 
a serious threat to the balance of the ecosystems and human health. These pollutants 
are composed of drug groups such as analgesics/anti-inflammatories, antibiotics, antidi-
abetic, antifungal, psychiatric drugs and synthetic hormones, to name a few. Some com-
monly found substances in the water body all over the world are naproxen, diclofenac, 
acetaminophen, aspirin and caffeine.  These chemicals are originated from mainly med-
ical, agriculture and animal husbandry activities. Humans and animals digestive system 
cannot convert all of the drugs consumed in these activities. These drugs then are re-
leased into the waste system, going through sewage treatment plants without being com-
pletely degraded and then discharged into the environment. There is evidence showing 
that when these micropollutants are allowed to accumulate, they can seriously affect 
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living entities within the natural food chains, which in turn can be harmful towards the 
ecosystems. 
Although much effort has been made to improve existing technologies, current common 
wastewater treatment is not effective in removing pharmaceutical residues from the wa-
ter influent. Traces of a wide variety of drugs have been detected in analyzing the effluent 
of common wastewater treatment plants. Therefore, more advance treatment techniques 
must be applied in order to reduce the micro-waste load in the wastewater. Currently, 
there are many techniques available with various effectiveness, and more will be in-
vented in the future. Some of the most commonly researched methods are adsorption 
using activated carbon, advance oxidation methods using ultraviolet (UV rays), ozona-
tion, biological treatment using fungi, microalgae and macrophytes. Activated carbon is 
effective in removing a lot of commonly found drugs, and produces effluent without toxic 
or pharmaceutical active side products, but very costly in terms of operation and mainte-
nance. Carbon ingredients, contact time, total carbon load, pores size, surface area, 
temperature, pH, hydrophobicity and available NOM amount are factors which can affect 
the adsorption strength of activated carbon. Advance oxidation processes can be based 
on UV light or ozone, with Fenton’s reagent, TiO2 and H2O2 being popular addition in 
order to improve its effectiveness. These methods can also produce appealing results, 
capable of degrading a wide range of pollutants with a rate of 90 % or higher. However, 
they also suffer from expensive operation costs. Moreover, advance oxidation processes 
can generate unwanted toxic side products. Biological treatments are some recent ef-
forts in imitating the ability of nature to degrade micropollutants. Usage of fungi, microal-
gae and macrophytes deliver promising results in removing these substances, while 
costing less and producing valuable biomass for other purposes. However, some phar-
maceuticals are resistant to this method and seasonal/environmental factors can de-
crease its effectiveness. Also, the combination of advanced treatment techniques can be 
an effective way to combine their strengths and compensate for the weaknesses of each 
technique. In conclusion, more studies must be conducted in order to find a proper tech-
nology that is versatile in removing pharmaceutical pollutants, has reasonable costs, 
produces no unwanted side-effects and could be integrated perfectly into the existing 
wastewater treatment systems.      
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